GENOVESE, Filippo
 Distribuzione geografica
Continente #
NA - Nord America 4.277
EU - Europa 3.809
AS - Asia 2.558
SA - Sud America 408
AF - Africa 58
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.117
Nazione #
US - Stati Uniti d'America 4.184
GB - Regno Unito 1.389
IT - Italia 961
SG - Singapore 774
CN - Cina 657
DE - Germania 338
BR - Brasile 321
VN - Vietnam 317
HK - Hong Kong 295
SE - Svezia 240
FR - Francia 168
RU - Federazione Russa 129
FI - Finlandia 113
PL - Polonia 105
KR - Corea 88
UA - Ucraina 80
IN - India 71
TR - Turchia 67
JP - Giappone 58
CA - Canada 50
ID - Indonesia 44
NL - Olanda 43
BD - Bangladesh 35
BE - Belgio 32
BG - Bulgaria 32
CH - Svizzera 30
AR - Argentina 29
IE - Irlanda 27
IQ - Iraq 27
MX - Messico 26
PK - Pakistan 22
ES - Italia 21
LT - Lituania 20
ZA - Sudafrica 19
AT - Austria 18
AE - Emirati Arabi Uniti 12
UZ - Uzbekistan 12
CZ - Repubblica Ceca 11
DK - Danimarca 11
PY - Paraguay 11
CO - Colombia 10
EC - Ecuador 10
MY - Malesia 10
VE - Venezuela 10
JO - Giordania 9
MA - Marocco 8
CL - Cile 7
LI - Liechtenstein 6
PE - Perù 6
PH - Filippine 6
SA - Arabia Saudita 6
CR - Costa Rica 5
DZ - Algeria 5
EG - Egitto 5
IL - Israele 5
IR - Iran 5
PS - Palestinian Territory 5
TW - Taiwan 5
AU - Australia 4
AZ - Azerbaigian 4
BH - Bahrain 4
GR - Grecia 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
NO - Norvegia 4
PT - Portogallo 4
TZ - Tanzania 4
AL - Albania 3
BY - Bielorussia 3
ET - Etiopia 3
GT - Guatemala 3
NG - Nigeria 3
RS - Serbia 3
TH - Thailandia 3
TN - Tunisia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
LV - Lettonia 2
NP - Nepal 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CG - Congo 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
Totale 11.110
Città #
Southend 1.170
Santa Clara 470
Singapore 465
Ashburn 448
Chandler 293
Hong Kong 285
Fairfield 261
Woodbridge 219
Hefei 202
San Jose 190
Ann Arbor 185
Houston 164
Nyköping 138
Dearborn 135
Jacksonville 124
Frankfurt am Main 119
Wilmington 112
Modena 107
Cambridge 105
Beijing 104
London 97
Seattle 95
Ho Chi Minh City 87
Kraków 77
New York 77
Hanoi 76
Los Angeles 76
Seoul 74
The Dalles 73
Helsinki 68
Tokyo 55
Council Bluffs 52
Milan 50
Shanghai 41
Munich 38
Orem 35
Bologna 34
Lauterbourg 32
Moscow 32
Princeton 32
Sofia 32
Fremont 31
Jakarta 31
Chicago 29
San Diego 29
Eugene 26
Izmir 26
Rome 26
Buffalo 25
Dublin 24
Da Nang 22
Porto Alegre 21
São Paulo 21
Warsaw 21
Brussels 20
Boardman 19
Redwood City 19
Lahore 17
Padova 17
Parma 17
Dallas 15
Phoenix 15
Turku 15
Atlanta 14
San Gimignano 14
Nuremberg 13
Rio de Janeiro 13
Stockholm 13
Bremen 12
Paris 12
Reggio Emilia 12
Amsterdam 11
Des Moines 11
Ferrara 11
Johannesburg 11
Ravenna 11
Zurich 11
Brno 10
Brooklyn 10
Chennai 10
Montreal 10
Naples 10
Vienna 10
Guangzhou 9
Haiphong 9
Mumbai 9
Prato 9
Tashkent 9
Toronto 9
Amman 8
Charleston 8
Columbus 8
Jinan 8
Kent 8
Salt Lake City 8
Verona 8
Vicenza 8
Belo Horizonte 7
Calcinaia 7
Denver 7
Totale 7.383
Nome #
Oxytetracycline-Protein Complex: The Dark Side of Pet Food 758
Enamel peptides reveal the sex of the Late Antique ‘Lovers of Modena’ 427
Metodo per la funzionalizzazione sito specifica di molecole proteiche 424
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 420
An autoregulatory loop controls the expression of the transcription factor NF-Y 415
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 386
Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers 379
Mass Spectrometric/Bioinformatic Identification of a Protein Subset That Characterizes the Cellular Activity of Anticancer Peptides 359
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 358
Identification and Characterization of New Proteins in Podocyte Dysfunction of Membranous Nephropathy by Proteomic Analysis of Renal Biopsy 356
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 344
Allosteric Inhibition of human Thymidylate Synthase. 338
Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer 337
A proteomic approach to investigate the mechanism of action of anticancer peptides 336
Proteomic Approach to the Detection of the Mechanism of Action of Anticancer Peptides 335
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 323
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 289
Chairperson EUTROC- Mayo Conference-Berlin - Preliminary characterization of pharmacodynamic biomarkers for LR-peptide growth inhibition of ovarian cancer (OC) cell models. 281
Invited lecture to 18th World Congress on Advances in Oncology and 16th International Symposium on Molecular Medicine 10-12 October, 2013, Creta Maris, Hersonissos, Crete, Greece 275
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 270
Design, synthesis and biological evaluation of non-covalent AmpC Beta-Lactamases inhibitors 270
MALDI-TOF MS as a tool for rapid Identification of Low Protein Affinity Drug Fragments. 266
Discovery and preliminary characterization of a novel inhibitor of the SOS response in Pseudomonas aeruginosa 261
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 259
FRET-based assay for sensing a cancer key protein functional state and inhibition by oligopeptides: Sitespecific Protein Chemical Modifications 256
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 243
EVALUATION OF LR STABILITY BY LC CHIP Q-TOF AND QUANTITATIVE DETERMINATION OF LR PEPTIDE CELL PENETRATION BY LC-MS/MS 238
Unusual Targeting of the human Thymidylate synthase interface: a tethering approach with mass-spectrometric detection. 228
Merging disulphide bonds for drug design Interfering with a cancer key protein 224
A dual-Omics approach to identify the modulated proteins/genes in THP-1 cells infected with different drug resistant L. infantum clinical isolates. 218
Development and validation of a new storage procedure to extend the in-use stability of azacitidine in pharmaceutical formulations 201
LC-MS/MS Helps Characterizing THP-1 Cells Proteome After Infection with Drug Resistant Leishmania Strains 198
Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136] (International Journal of Pharmaceutics: X (2022) 4, (S2590156722000251), (10.1016/j.ijpx.2022.100136)) 165
Insights into host-target interaction from the proteome modulation analysis through untargeted LC-MS/MS Proteomics of drug resistant L infantum-THP1 infected cells 164
LC-MS/MS proteomics for the rapid and selective screening of drug resistances in Leishmania infantum clinical isolates 161
Deciphering Host–Parasite Interplay in Leishmania Infection through a One Health View of Proteomics Studies on Drug Resistance 159
Label-Free Mass Spectrometry Proteomics Reveals Different Pathways Modulated in THP-1 Cells Infected with Therapeutic Failure and Drug Resistance Leishmania infantum Clinical Isolates 157
Quantitative comparison of the protein corona of nanoparticles with different matrices 130
Totale 11.208
Categoria #
all - tutte 33.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021383 0 0 0 0 0 0 0 0 0 257 79 47
2021/2022681 39 82 41 43 27 48 56 38 60 40 120 87
2022/2023920 95 121 60 91 81 122 43 120 71 13 56 47
2023/2024937 33 39 44 73 232 74 156 88 23 26 59 90
2024/20252.103 80 29 75 160 386 281 183 128 196 83 223 279
2025/20263.050 243 145 227 377 554 247 475 192 297 293 0 0
Totale 11.208